BioMedNewsBreaks – Predictive Oncology (NASDAQ: POAI) Ranked as Buy in Litchfield Hills Recent Analyst Report
Feb 2, 2021
Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, has been rated as a “Buy” in the first analyst coverage report released by equity research firm Litchfield Hills Research LLC. POAI was listed as a “Buy” under the report’s three-tiered (buy, hold, sell) rating system. Litchfield Hills Research strictly follows FINRA standards for quality and objectivity, and the research firm has certified that the publication is compliant with FINRA research rules 2241, 3110. In addition, Litchfield confirmed that the report has been reviewed by a supervisory senior analyst and is MiFID II compliant as well as classified as minor non-monetary benefit under MiFID II. In the announcement it was noted that Litchfield develops its price target, financial models, peer comparisons and investment thesis without input from management of the company.
To view the full report on POAI, visit https://ibn.fm/NE2yB
To view the full press release, visit https://ibn.fm/IZc2Y
About Predictive Oncology Inc.
Predictive Oncology operates through three segments (domestic, international and other), which contain four subsidiaries; Helomics, TumorGenesis, Skyline Medical and Soluble Biotech. Helomics applies artificial intelligence to its rich data gathered from patient tumors to both personalize cancer therapies for patients and drive the development of new targeted therapies in collaborations with pharmaceutical companies. TumorGenesis Inc. specializes in media that help cancer cells grow and retain their DNA/RNA (“DNA/RNA”) and proteomic signatures, providing researchers with a tool to expand and study cancer cell types found in tumors of the blood and organ systems of all mammals, including humans. Skyline Medical markets its patented and FDA cleared STREAMWAY System, which automates the collection, measurement and disposal of waste fluid, including blood, irrigation fluid and others, within a medical facility, through both domestic and international divisions. Soluble Biotech is a provider of soluble and stable formulations for proteins including vaccines, antibodies, large and small proteins and protein complexes. For more information about the company, please visit www.Predictive-Oncology.com.
NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://ibn.fm/POAI
About BioMedWire
BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information please visit https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
[email protected]
BioMedWire is part of the InvestorBrandNetwork
More News
LIST: The Marcos administration’s cybersecurity efforts
The Marcos administration details its initiatives aimed to be completed by 2028 under the second National Cybersecurity Plan
Analyst stands by VP Duterte’s 20% GenCorp interest
MANILA, Philippines — The House prosecution’s forensic accounting expert witness, lawyer-accountant Alexander Cabrera, stood by his finding on Monday that Vice President Sara Duterte had a 20-percent interest in GenCorp Industries Inc., even without written contracts or subscription agreements directly establishing her stake in the firm. Cabrera, chairman emeritus of Isla Lipana & Co. (PwC Philippines),
Vietnam could lose winter by 2100 as major cities face 100 more hot days, scientists warn
Inner Ho Chi Minh City could see 90-100 more days a year above 35 degrees Celsius by the end of the century under a high-emissions scenario, and inner Hanoi 50-90 more, Vietnam's updated climate projections show.
Which Southeast Asian country has the cheapest household electricity?
Electricity in this country costs 2.5 cents per kilowatt-hour, making it the cheapest in Southeast Asia.
Victims of Apax Leaders English school boss's $327M fraud rise to 10,123
Nguyen Ngoc Thuy, who ran English language school Apax Leaders, has been indicted for a second time, accused of fraudulently appropriating VND8.459 trillion (US$327 million) from 10,123 people, 60 more than in his first indictment.
LIVE UPDATES: Sara Duterte Impeachment Trial (October 13, 2026)
The impeachment trial of Vice President Sara Duterte will start at 1 p.m. on Tuesday, October 13, at the Senate impeachment court. Here are the latest news and updates.
Sharon Cuneta, daughter Kakie attend Duterte impeachment trial
MANILA, Philippines — Megastar Sharon Cuneta and her daughter, Frankie “Kakie” Pangilinan, attended the impeachment trial of Vice President Sara Duterte at the Senate on Monday, the 38th day of the proceedings. Cuneta, the wife of Sen. Francis “Kiko” Pangilinan, was spotted at the Senate gallery alongside their daughter, Kakie. After his interpellation of the
PDI recognized by PCG during first Stakeholders’ Night
MANILA, Philippines — The Philippine Daily Inquirer (PDI) has been recognized by the Philippine Coast Guard (PCG) for its support to the missions and objectives of the agency. The award was given to the newspaper during the PCG’s Stakeholders’ Night on Monday, Oct. 12. READ: SWS poll: Filipinos choose AFP, PCG modernization as maritime priority
Air pollution spreads to more Cebu areas
CEBU CITY, Philippines — More local government units in Metro Cebu suspended in-person classes on Monday, Oct. 12, after air quality deteriorated to “very unhealthy” levels once again. But this time, local pollutants such as vehicle emissions and industrial pollution, and not the transboundary haze from the raging forest and peat fires in Indonesia’s Kalimantan
Highlights: Day 38 of Sara Duterte impeachment trial | Oct. 12, 2026
MANILA, Philippines – Day 38 of the trial on Monday centered on the cross-examination of prosecution forensic financial analyst Alexander Cabrera, who conceded that his report showing P817 million in alleged unexplained wealth was based on available documents and did not include records submitted directly by Duterte or her husband, lawyer Manases Carpio. Defense counsel
Sara Duterte impeachment trial Day 39: What to expect
The Senate impeachment court on Tuesday is set to tackle the manifestation of the House prosecution panel to drop Article III or the bribery charges in the trial of Vice President Sara Duterte.
‘Kutseros’ preserving Vigan heritage get rice aid
VIGAN CITY, ILOCOS SUR, Philippines — The provincial government distributed rice assistance to “kutseros,” or horse-drawn carriage drivers, on Monday (Oct. 12) in recognition of their contribution to preserving the cultural heritage of Vigan, a United Nations Educational, Scientific and Cultural Organization (UNESCO) World Heritage Site. The assistance aims to ease the daily expenses of
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.